Yang Li-Xuan, Chen Fang-Yu, Yu Hai-Long, Liu Pin-Yi, Bao Xin-Yu, Xia Sheng-Nan, Gu Yue, Xu Yun, Cao Xiang
Department of Neurology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.
Department of Neurology, Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Institute of Brain Science, Nanjing University, Nanjing, China.
Ann Transl Med. 2020 Nov;8(21):1344. doi: 10.21037/atm-20-3470.
Based on accumulating evidence, excessive activation of microglia-mediated inflammatory responses plays an essential role in ischemic stroke. Poncirin (Pon) exerts anti-hyperalgesic, anti-osteoporotic and anti-tumor effects on various diseases. However, the roles of Pon in microglial activation and the underlying mechanism have not been elucidated. This study aimed to explore whether Pon inhibits lipopolysaccharide (LPS)-induced microglial neuroinflammation and protects against brain ischemic injury in experimental stroke in mice.
Primary microglia cells were prepared from the cerebral cortices of 1- to 2-day-old C57BL/6J mice. Murine BV2 cells and primary microglia were stimulated with LPS and the effects of a non-cytotoxic concentration of Pon on LPS-stimulated pro-inflammatory factors were measured using real-time PCR and enzyme-linked immunosorbent assays (ELISAs). Western blot analyses were used for mechanistic studies. In an study, 8-week-old male C57BL/6J mice were subjected to focal cerebral ischemia through middle cerebral artery occlusion (MCAO). Pon (30 mg/kg, i.p.) or the same volume of saline was administered after the MCAO model was established, and the infarct volume was evaluated using 2,3,5-triphenyltetrazolium chloride (TTC) staining. We also evaluated animal behaviours, the expression of pro-inflammatory cytokines and microglial activation in the ischemic hemisphere.
Pon prevented the release of nitric oxide (NO), prostaglandin E2 (PGE2), interleukin (IL)-1β, IL-6 and tumor necrosis factor-alpha (TNF-α) in both BV2 cells and primary microglia stimulated with LPS. The inhibitory effects of Pon were associated with the regulation of the ERK1/2, JNK and nuclear factor kappa B (NF-κB) signaling pathways. In mice that underwent MCAO, Pon administration decreased the lesion size and improved neurological deficits. Furthermore, Pon attenuated the production of inflammatory cytokines mainly by restraining microglial activation after ischemic stroke.
Based on the findings from the present study, Pon provides neuroprotection through its anti-inflammatory effects on microglia and it may be a useful treatment for ischemic stroke.
基于越来越多的证据,小胶质细胞介导的炎症反应过度激活在缺血性卒中中起重要作用。柚皮苷(Pon)对多种疾病具有抗痛觉过敏、抗骨质疏松和抗肿瘤作用。然而,Pon在小胶质细胞激活中的作用及其潜在机制尚未阐明。本研究旨在探讨Pon是否能抑制脂多糖(LPS)诱导的小胶质细胞神经炎症,并在小鼠实验性卒中中预防脑缺血损伤。
从1至2日龄C57BL/6J小鼠的大脑皮质制备原代小胶质细胞。用LPS刺激小鼠BV2细胞和原代小胶质细胞,并用实时PCR和酶联免疫吸附测定(ELISA)检测非细胞毒性浓度的Pon对LPS刺激的促炎因子的影响。采用蛋白质免疫印迹分析进行机制研究。在一项研究中,对8周龄雄性C57BL/6J小鼠进行大脑中动脉闭塞(MCAO)以造成局灶性脑缺血。在建立MCAO模型后给予Pon(30mg/kg,腹腔注射)或等体积的生理盐水,并使用2,3,5-三苯基氯化四氮唑(TTC)染色评估梗死体积。我们还评估了动物行为、促炎细胞因子的表达以及缺血半球中小胶质细胞的激活情况。
Pon可抑制LPS刺激的BV2细胞和原代小胶质细胞中一氧化氮(NO)、前列腺素E2(PGE2)、白细胞介素(IL)-1β、IL-6和肿瘤坏死因子-α(TNF-α)的释放。Pon的抑制作用与细胞外信号调节激酶1/2(ERK1/2)、c-Jun氨基末端激酶(JNK)和核因子κB(NF-κB)信号通路的调节有关。在接受MCAO的小鼠中,给予Pon可减小病变大小并改善神经功能缺损。此外,Pon主要通过抑制缺血性卒中后小胶质细胞的激活来减轻炎症细胞因子的产生。
基于本研究的结果,Pon通过其对小胶质细胞的抗炎作用提供神经保护,可能是缺血性卒中的一种有效治疗方法。